News | May 29, 2026
AbbVie wins FDA nod for DECNUPAZ in rare blood cancer
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
The decision marks a key step in the centralized EU review process
The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments
Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance
The development comes as stroke remains one of the world’s biggest health threats
Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
